References
- Ariel IM, Briceno M (1975). Rhabdomyosarcoma of the extremities and trunk: analysis of 150 patients treated by surgical resection. J Surg Oncol, 7, 269-87. https://doi.org/10.1002/jso.2930070403
- Arndt CA, Hawkins DS, Meyer WH, et al (2008). Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer, 50, 33-6. https://doi.org/10.1002/pbc.21093
- Arndt CA, Stoner JA, Hawkins DS, et al (2009). Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol, 27, 5182-8. https://doi.org/10.1200/JCO.2009.22.3768
- Esnaola NF, Rubin BP, Baldini EH, et al (2001). Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg, 234, 215-23. https://doi.org/10.1097/00000658-200108000-00012
- Ferrari A, Dileo P, Casanova M, et al (2003). Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer, 98, 571-80. https://doi.org/10.1002/cncr.11550
- Hawkins WG, Hoos A, Antonescu CR, et al (2001). Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer, 91, 794-803. https://doi.org/10.1002/1097-0142(20010215)91:4<794::AID-CNCR1066>3.0.CO;2-Q
- Little DJ, Ballo MT, Zagars GK, et al (2002). Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer, 95, 377-88. https://doi.org/10.1002/cncr.10669
- National Comprehensive Cancer Network. Soft Tissue Sarcoma (Version 1.2015) [Online].
- Newton WA, Jr., Gehan EA, Webber BL, et al (1995). Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification--an Intergroup Rhabdomyosarcoma Study. Cancer, 76, 1073-85. https://doi.org/10.1002/1097-0142(19950915)76:6<1073::AID-CNCR2820760624>3.0.CO;2-L
- Parham DM, Ellison DA (2006). Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med, 130, 1454-65.
- Sezgin G, Acipayam C, Bayram I, et al (2015). Replacing actinomycin-D with Carboplatin for newly diagnosed rhabdomyosarcoma. Asian Pac J Cancer Prev, 16, 3351-4. https://doi.org/10.7314/APJCP.2015.16.8.3351
- Simon JH, Paulino AC, Ritchie JM, et al (2003). Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma, 7, 1-7. https://doi.org/10.1080/1357714031000114147
- Stock N, Chibon F, Binh MB, et al (2009). Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol, 33, 1850-9. https://doi.org/10.1097/PAS.0b013e3181be6209
- Sultan I, Qaddoumi I, Yaser S, et al (2009). Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol, 27, 3391-7. https://doi.org/10.1200/JCO.2008.19.7483
Cited by
- Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS pp.00224790, 2019, https://doi.org/10.1002/jso.25401